South Korea · Delayed Price · Currency is KRW Amicogen Statistics
Total Valuation
Amicogen has a market cap or net worth of KRW 63.20 billion. The enterprise value is 115.33 billion.
| Market Cap | 63.20B |
| Enterprise Value | 115.33B |
Important Dates
The next estimated earnings date is Friday, November 13, 2026.
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Amicogen has 70.45 million shares outstanding. The number of shares has increased by 11.41% in one year.
| Current Share Class | 70.45M |
| Shares Outstanding | 70.45M |
| Shares Change (YoY) | +11.41% |
| Shares Change (QoQ) | +10.62% |
| Owned by Insiders (%) | 3.70% |
| Owned by Institutions (%) | 0.33% |
| Float | 64.93M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.35 |
| PB Ratio | 0.53 |
| P/TBV Ratio | 0.55 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.47 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.02, with a Debt / Equity ratio of 0.51.
| Current Ratio | 1.02 |
| Quick Ratio | 0.62 |
| Debt / Equity | 0.51 |
| Debt / EBITDA | n/a |
| Debt / FCF | -36.21 |
| Interest Coverage | -2.03 |
Financial Efficiency
Return on equity (ROE) is -16.77% and return on invested capital (ROIC) is -7.86%.
| Return on Equity (ROE) | -16.77% |
| Return on Assets (ROA) | -3.88% |
| Return on Invested Capital (ROIC) | -7.86% |
| Return on Capital Employed (ROCE) | -9.00% |
| Weighted Average Cost of Capital (WACC) | 7.03% |
| Revenue Per Employee | 197.82M |
| Profits Per Employee | -81.75M |
| Employee Count | 236 |
| Asset Turnover | 0.21 |
| Inventory Turnover | 3.75 |
Taxes
In the past 12 months, Amicogen has paid 1.38 billion in taxes.
| Income Tax | 1.38B |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -77.58% in the last 52 weeks. The beta is 0.16, so Amicogen's price volatility has been lower than the market average.
| Beta (5Y) | 0.16 |
| 52-Week Price Change | -77.58% |
| 50-Day Moving Average | 1,034.50 |
| 200-Day Moving Average | 1,547.62 |
| Relative Strength Index (RSI) | 41.03 |
| Average Volume (20 Days) | 451,342 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Amicogen had revenue of KRW 46.69 billion and -19.29 billion in losses. Loss per share was -315.04.
| Revenue | 46.69B |
| Gross Profit | 7.96B |
| Operating Income | -14.06B |
| Pretax Income | -18.64B |
| Net Income | -19.29B |
| EBITDA | -4.89B |
| EBIT | -14.06B |
| Loss Per Share | -315.04 |
Balance Sheet
The company has 9.52 billion in cash and 60.78 billion in debt, with a net cash position of -51.26 billion or -727.60 per share.
| Cash & Cash Equivalents | 9.52B |
| Total Debt | 60.78B |
| Net Cash | -51.26B |
| Net Cash Per Share | -727.60 |
| Equity (Book Value) | 118.87B |
| Book Value Per Share | 1,674.84 |
| Working Capital | 955.15M |
Cash Flow
In the last 12 months, operating cash flow was -606.32 million and capital expenditures -1.07 billion, giving a free cash flow of -1.68 billion.
| Operating Cash Flow | -606.32M |
| Capital Expenditures | -1.07B |
| Depreciation & Amortization | 9.17B |
| Net Borrowing | -34.90B |
| Free Cash Flow | -1.68B |
| FCF Per Share | -23.82 |
Margins
Gross margin is 17.05%, with operating and profit margins of -30.12% and -41.33%.
| Gross Margin | 17.05% |
| Operating Margin | -30.12% |
| Pretax Margin | -39.94% |
| Profit Margin | -41.33% |
| EBITDA Margin | -10.47% |
| EBIT Margin | -30.12% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 25.00, which amounts to a dividend yield of 2.79%.
| Dividend Per Share | 25.00 |
| Dividend Yield | 2.79% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -11.41% |
| Shareholder Yield | -8.63% |
| Earnings Yield | -30.53% |
| FCF Yield | -2.66% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on December 13, 2023. It was a forward split with a ratio of 2.
| Last Split Date | Dec 13, 2023 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
Amicogen has an Altman Z-Score of 0.62 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.62 |
| Piotroski F-Score | 3 |